InMed Pharmaceuticals Inc. (INM)

NASDAQ: INM · Real-Time Price · USD

Compare

2.460

+0.200 (8.85%)

At close: Oct 8, 2025, 4:00 PM EDT

2.430

-0.030 (-1.22%)

After-hours: Oct 8, 2025, 7:25 PM EDT

InMed Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Revenue	4.94	4.6	4.14	1.09	-	Upgrade
Revenue Growth (YoY)	7.50%	11.18%	279.61%	-	-	Upgrade
Cost of Revenue	3.24	3.5	2.73	0.55	-	Upgrade
Gross Profit	1.71	1.1	1.4	0.54	-	Upgrade
Selling, General & Admin	6.56	5.8	5.85	6.67	4.48	Upgrade
Research & Development	2.85	3.22	3.73	7.28	5.34	Upgrade
Operating Expenses	9.62	9.24	9.78	14.14	9.94	Upgrade
Operating Income	-7.92	-8.13	-8.38	-13.59	-9.94	Upgrade
Interest & Investment Income	0.16	0.53	0.49	0.1	0.02	Upgrade
Currency Exchange Gain (Loss)	-0.03	-0.06	-0.05	-0.12	-0.16	Upgrade
Other Non Operating Income (Expenses)	-0.37	-	-	-	-0.12	Upgrade
EBT Excluding Unusual Items	-8.16	-7.67	-7.93	-13.61	-10.2	Upgrade
Merger & Restructuring Charges	-	-	-	-0.2	-	Upgrade
Impairment of Goodwill	-	-	-	-2.02	-	Upgrade
Asset Writedown	-	-	-	-1.45	-	Upgrade
Other Unusual Items	-	-	-	-1.31	-	Upgrade
Pretax Income	-8.16	-7.67	-7.93	-18.6	-10.2	Upgrade
Income Tax Expense	-	0.01	0.01	-	-	Upgrade
Net Income	-8.16	-7.68	-7.95	-18.6	-10.2	Upgrade
Net Income to Common	-8.16	-7.68	-7.95	-18.6	-10.2	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	Upgrade
Shares Change (YoY)	156.13%	211.26%	336.59%	108.64%	28.72%	Upgrade
EPS (Basic)	-8.36	-20.14	-64.92	-663.32	-759.16	Upgrade
EPS (Diluted)	-8.36	-20.14	-64.92	-663.32	-759.16	Upgrade
Free Cash Flow	-7.77	-7	-7.45	-15.62	-9.79	Upgrade
Free Cash Flow Per Share	-7.96	-18.36	-60.81	-557.14	-728.60	Upgrade
Gross Margin	34.53%	23.95%	33.93%	49.89%	-	Upgrade
Operating Margin	-160.20%	-176.92%	-202.60%	-1247.60%	-	Upgrade
Profit Margin	-165.14%	-166.94%	-192.18%	-1707.32%	-	Upgrade
Free Cash Flow Margin	-157.14%	-152.14%	-180.02%	-1434.03%	-	Upgrade
EBITDA	-7.71	-7.91	-8.18	-13.41	-9.82	Upgrade
EBITDA Margin	-155.89%	-172.15%	-197.71%	-	-	Upgrade
D&A For EBITDA	0.21	0.22	0.2	0.19	0.12	Upgrade
EBIT	-7.92	-8.13	-8.38	-13.59	-9.94	Upgrade
EBIT Margin	-160.20%	-176.92%	-202.60%	-	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q